Aggregation has the potential to add more complexity and cost to serialization, which will already pose significant challenges to the life sciences supply chain in coming years as companies prepare for global serialization deadlines.

 

How can your pharmaceutical company best approach aggregation? Download the full eBook by clicking "Get eBook."